| Spotlight |
 |
|
Experts say that closing the data gap with inclusionary research and educating investors on the promise of women’s health innovations are key steps forward.
|
| Latest news |
|
|
The Swiss pharma giant now joins a growing list of big pharma and biotech players exploring the RNAi approach’s promise in treating obesity.
|
|
|
The planned facility, designated as the Translational Hub for THRIVE, will focus on the development, validation, and adoption of NAMs.
|
|
|
GenSci holds exclusive Chinese rights to Camcevi, covering central precocious puberty, premenopausal breast cancer, and advanced prostate cancer.
|
|
|
Teva said it is debuting the drug to overcome adherence issues with an oral counterpart and improve symptom outcomes.
|
|
|
Perceptive and Nucleus will direct qualified customer opportunities to the other across the development pipeline.
|
|
|
|
